Vitrue Health, a London, UK-based provider of a digital musculoskeletal (MSK) health platform for workplaces, raised $4M in funding.

英国伦敦维特鲁健康公司（Vitrue Health）为工作场所提供数字肌肉骨骼（MSK）健康平台，筹集了400万美元资金。

The round, which brought the total amount to $7M, was led by MC Ventures and Hambro Perks, with participation from Simplyhealth Ventures, Crista Galli Ventures, and Chris Bruce.

这轮投资总额达到700万美元，由MC Ventures和Hambro Perks牵头，Simplyhealth Ventures、Crista Galli Ventures和Chris Bruce参与。

The company intends to use the funds to further grow the team and advance its expansion across the US and new markets in Europe.

该公司打算利用这些资金进一步壮大团队，并推动其在美国和欧洲新市场的扩张。

Led by CEO Shane Lowe, Vitrue Health is a technology startup specialising in reducing musculoskeletal pain. Utilising computer vision and biomechanical analysis, the company offers innovative solutions for workplace health assessments that are accurate, holistic and personalised. Its platform aims to reduce musculoskeletal pain in the workplace, aiding employers in fulfilling their regulatory obligations at scale.

Vitrue Health由首席执行官Shane Lowe领导，是一家专门从事减轻肌肉骨骼疼痛的技术初创公司。该公司利用计算机视觉和生物力学分析，为准确、全面和个性化的工作场所健康评估提供创新解决方案。其平台旨在减少工作场所的肌肉骨骼疼痛，帮助雇主大规模履行监管义务。

It is used by brands such as Bupa, the NHS, Hastings Direct and Campari.

它被Bupa、NHS、Hastings Direct和Campari等品牌使用。

Commenting on the news, Shane Lowe said “Musculoskeletal health conditions have been a societal problem across the world for decades, and our data shows that rates of pain have massively increased since the rise of hybrid working. With this new funding, we’ll be able to continue our growth to reduce the financial and health costs for employers and their teams.” 

Shane Lowe在评论这条新闻时说：“几十年来，肌肉骨骼健康状况一直是全世界的一个社会问题，我们的数据显示，自从混合工作兴起以来，疼痛率大幅上升。有了这项新资金，我们将能够继续增长，以降低雇主及其团队的财务和健康成本。”